(PDF) Commentary on the Draft Revised Guideline on the

Commentary on the Draft Revised Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use

Environmental Sciences Europe - Germany

doi 10.1186/s12302-019-0198-9

Full Text

Abstract

Available in full text

Categories

Date

March 11, 2019

Authors

Susanne Brendler-Schwaab

Eadaoin Griffin

Caroline Moermond

Laila Sortvik Nilssen

Henry Stemplewski

Ines Roennefahrt

Publisher

Springer Science and Business Media LLC

Related search

International Logistics Criteria on Medicinal Products for Human Use

International Journal of Asian Social Science

English

Environmental Risk Assessment of Human and Veterinary Medicinal Products - Challenges and Ways of Improvement

Microchemical Journal

Analytical Chemistry

English

Evaluation and Use of Epidemiological Evidence for Environmental Health Risk Assessment: WHO Guideline Document.

Environmental Health Perspectives

Occupational Health

English

Environmental Risk Assessment of Pharmaceuticals &Mdash;Environmental Risk of Medicinal Products Which Health Professionals Should Be Aware Of—

Japanese Journal of Clinical Pharmacology and Therapeutics

English

Fri0609 European Medicines Agency's Guideline on the Clinical Investigation of Medicinal Products for the Treatment of Rheumatoid Arthritis

English

Survey Design in the Assessment of the Implementation of Risk Minimisation Measures for Medicinal Products

Value in Health

Occupational Health

English

Outcome of a Public Consultation on the Draft Update of the Guidance on the Use of the Benchmark Dose Approach in Risk Assessment

EFSA Supporting Publications

English

Outcome of a Public Consultation on the Draft Risk Assessment of Aflatoxins in Food

EFSA Supporting Publications

English

The Use of Medicinal Plants in Human Healthcare: A Scoop on Safety

Pharmaceutical Regulatory Affairs: Open Access

English